Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

Share Price is delayed by 15 minutes
Get Live Data
219.00    0.00 (0.00%)
Bid:
201.00
Ask:
0.00
Spread: 18.50 (9.204%)
Market Cap: £475.74m
AMS Live PriceLast checked at - London Stock Exchange

Intraday Advanced Medical Solutions Group Share Chart

Director/PDMR Shareholding

1 May 2014 14:32

RNS Number : 0951G
Advanced Medical Solutions Grp PLC
01 May 2014
 



1 May 2014

Advanced Medical Solutions Group plc ("AMS" or the "Company")

Directors' shareholdings

Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that the following Directors purchased ordinary shares of 5 pence each ("Ordinary Shares") on 30 April 2014, as part of the Deferred Share Bonus Plan. These Ordinary Shares were bought at a price of 126 pence per share and, under the terms of the Plan, will be held in trust on their behalf.

Following these transactions the beneficial ownership of Chris Meredith and Mary Tavener is as follows:

Director

Date purchased

Shares Purchased

Resultant Holding

% of issued share capital

Chris Meredith, Chief Executive Officer

 

30 April 2014

2,269

1,185,207

0.6

Mary Tavener, Group Finance Director

 

30 April 2014

1,428

1,774,470

0.9

 

For further information:

Advanced Medical Solutions Group plc

Mary Tavener, Group Finance Director +44 (0) 1606 545 508

Investec (NOMAD)

Daniel Adams +44 (0) 20 7597 5970

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBXGDUBXGBGSB
Date   Source Headline
11th May 20204:01 pmRNSDirector/PDMR Shareholding
30th Apr 20202:00 pmRNSTotal Voting Rights
17th Apr 20204:30 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSPCA Dealing
6th Apr 20209:26 amRNSDirector/PDMR and PCA Shareholding
6th Apr 20207:01 amRNSClinical Development Programme
6th Apr 20207:00 amRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSCOVID-19 Update
30th Mar 20209:06 amRNSHoldings in Company
13th Mar 20205:00 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSUnaudited Preliminary Results
10th Mar 20207:00 amRNSBlock listing Interim Review
10th Mar 20207:00 amRNSFDA Approval of LiquiBand® Rapid(TM)
11th Feb 202010:03 amRNSHolding(s) in Company
15th Jan 20207:00 amRNSYear End Trading Update
31st Dec 201912:18 pmRNSTotal Voting Rights
2nd Dec 20197:00 amRNSAcquisition of Biomatlante SA
29th Nov 20193:08 pmRNSTotal Voting Rights
29th Nov 20197:00 amRNSThird party sterilisation failure
31st Oct 20193:13 pmRNSTotal Voting Rights
31st Oct 20193:09 pmRNSHolding(s) in Company
16th Sep 201911:15 amRNSHolding(s) in Company
16th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSInterim Results
6th Sep 20197:00 amRNSBlock listing Interim Review
8th Aug 20197:00 amRNSNotice of Interim Results
31st Jul 20195:52 pmRNSTotal Voting Rights
30th Jul 20197:00 amRNSFDA approval for two advanced woundcare ranges
28th Jun 20192:23 pmRNSTotal Voting Rights
21st Jun 20197:00 amRNSTrading Update
5th Jun 20195:29 pmRNSResult of AGM
5th Jun 20197:00 amRNSNotice of AGM
31st May 20193:10 pmRNSTotal Voting Rights
14th May 20197:00 amRNSIDE received for LiquiBand Fix8 in US
30th Apr 20194:56 pmRNSTotal Voting Rights
30th Apr 20199:40 amRNSNotice of Annual General Meeting and Annual Report
29th Apr 20195:27 pmRNSDirector/PDMR Shareholding
4th Apr 201910:16 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSHolding(s) in Company
13th Mar 20197:00 amRNSUnaudited preliminary results
6th Mar 20199:13 amRNSBlock listing Interim Review
4th Mar 20192:24 pmRNSHolding(s) in Company
19th Feb 20197:00 amRNSNotice of Results
12th Feb 20194:23 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSAcquisition of Sealantis
31st Dec 20187:00 amRNSManagement Change
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 20187:00 amRNSFix8 approved in Europe
18th Dec 20187:00 amRNSTrading Update
30th Nov 20181:40 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.